Diana Cholakian Pearre, MD
Gynecologic Oncology · Burbank, CANPI 1659714475
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (46.1%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. 26 manufacturers reported payments, led by AbbVie at 53.7% of the total. 2025 is the largest year on record at $3,096, more than ten times the $49 reported in 2019.
Across 77 payments — averaging $57.43 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- Intuitive Surgical$556
- Astellas Pharma US Inc$276
- Sumitomo Pharma America, Inc.$273
- Myriad Genetic Laboratories, Inc.$121
- Caris MPI, Inc.$104
- plus $716 from 20 others
Across 1 payment — averaging $40,000 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Genmab U.S., Inc.$40K
What the payments were for
- Consulting fees$1,95044%
- Travel & lodging$2385%
- Food & beverage$2,04046%
- Education$1944%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 18 | $2,375 |
| Intuitive Surgical | 11 | $556 |
| Astellas Pharma US Inc | 8 | $276 |
| Sumitomo Pharma America, Inc. | 8 | $273 |
| Myriad Genetic Laboratories, Inc. | 2 | $121 |
| Caris MPI, Inc. | 3 | $104 |
| Seagen Inc. | 1 | $95 |
| Eisai Inc. | 4 | $94 |
| Pfizer | 3 | $60 |
| Baxter Healthcare | 1 | $59 |
| Daiichi Sankyo Inc. | 2 | $59 |
| Mayne Pharma Commercial LLC | 2 | $44 |
| Merck | 1 | $35 |
| Boston Scientific | 1 | $28 |
| Verastem, Inc. | 1 | $26 |
| Tesaro, Inc. | 1 | $26 |
| GSK | 1 | $25 |
| Pacira Pharmaceuticals Incorporated | 1 | $22 |
| Mycovia Pharmaceuticals, Inc. | 1 | $21 |
| Coopersurgical, Inc. | 1 | $20 |
| Medtronic | 1 | $20 |
| Therapeuticsmd, Inc. | 1 | $18 |
| Ascend Therapeutics US, LLC | 1 | $18 |
| Myovant Sciences Inc. | 1 | $16 |
| Hologic Sales And Service, LLC | 1 | $16 |
| Teleflex LLC | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Elahere$1,950
- Da Vinci Surgical System$348
- MYFEMBREE$136
How this compares
$4,422 in reported general payments places this provider in the 65th percentile of 152 gynecologic oncology providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 30 | $1,586 |
| Fluconazole | 14 | $118 |
| Triamcinolone Acetonide | 28 | $88 |
| Ibuprofen | 24 | $56 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 11 | $48 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 13 | $38 |
Paid to pharmacies, not to this prescriber.
Other gynecologic oncology in Burbank
- John ChanSan Francisco$2M
- Dana ChaseLos Angeles$1.3M
- Ramez EskanderEncinitas$706K
- Krishnansu TewariOrange$495K
- Fabio CappucciniOrange$313K
- Mehdi Moslemi-KebriaUpland$225K
- Amer KaramStanford$168K
- Rebecca BrooksSacramento$133K
- Kenneth KimWest Hollywood$88K
- Oliver DorigoStanford$85K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.